Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

The No. 1 Reason to Claim Social Security at Age 62
The No. 1 Reason to Claim Social Security at Age 62

Social Security benefits can be claimed at 62.

Most financial experts advise against doing that because starting checks ASAP means accepting less monthly income. See, Social Security is designed so

Is Apple Going to Expand Into Smart Eyewear?
Is Apple Going to Expand Into Smart Eyewear?

Apple (NASDAQ: AAPL) is known for its innovative product lineup, and there's no shortage of speculation about what products it might roll out next. In this segment of Backstage Pass, recorded on

Fan of F1? Here's How You Can Invest in Your Favorite Sport
Fan of F1? Here's How You Can Invest in Your Favorite Sport

In this video, I will be talking about how every F1 fan can invest in their favorite sport. I will explain why Formula One Group (NASDAQ: FWONA) has become very popular in recent years and how it

Want More Monthly Income? Invest in These 3 Stocks
Want More Monthly Income? Invest in These 3 Stocks

Whether you're a retiree looking to help pay your bills or you just want to save up for your next vacation, everyone can use some extra cash every month. And one way you can generate more money for

Etsy Earnings: Numbers Investors Need to Know
Etsy Earnings: Numbers Investors Need to Know

Etsy (NASDAQ: ETSY) made a name for itself during the pandemic, as its sellers became a key supplier of face masks and other consumer necessities. This adaptability showcased the value in its

Pfizer's Next mRNA Vaccine Candidate Goes Beyond COVID-19
Pfizer's Next mRNA Vaccine Candidate Goes Beyond COVID-19

Pfizer (NYSE: PFE) continues to rake in billions of dollars in sales for its messenger RNA (mRNA) COVID-19 vaccine developed with BioNTech (NASDAQ: BNTX). However, the big drugmaker has bigger plans

Have $500? This Under-the-Radar Stock Could Make You Richer From the Biotech Boom
Have $500? This Under-the-Radar Stock Could Make You Richer From the Biotech Boom

Hardly a week passes where we don't learn of some cutting-edge research that helps us better understand our bodies and how to harness them to combat disease. The revolutionary vaccines for COVID-19

3 Top Stocks Under $100
3 Top Stocks Under $100

Despite the enhanced market volatility that investors have been seeing lately, there's still no shortage of excellent stocks to buy. In this Backstage Pass segment, recorded on Oct. 6, Fool

3 Dividend Stocks That Hiked Their Payouts by More Than 10% This Year
3 Dividend Stocks That Hiked Their Payouts by More Than 10% This Year

Dividend stocks that hike their payouts by generous amounts should definitely be on your watch list. If a company were to raise its dividend payments by 10% for more than seven years in a row, your

3 5G Stocks to Buy in October
3 5G Stocks to Buy in October

The era of 5G is here, and there are several ways to invest behind the improvements that faster download speeds will bring smartphone users.

Here's why I believe Apple (NASDAQ: AAPL), Micron

Domino's Marks the End of an Epic Streak in the Fast-Food Industry
Domino's Marks the End of an Epic Streak in the Fast-Food Industry

It was bound to happen eventually. Domino's (NYSE: DPZ) this past week announced that third-quarter sales dropped in the core U.S. market, ending one of the most impressive growth streaks in the

What Investors Should Look for When Fastly Reports Earnings
What Investors Should Look for When Fastly Reports Earnings

Fastly (NYSE: FSLY) has struggled in recent months. This cloud computing company reported weak earnings in the first quarter, then suffered a serious outage in June, which slowed growth even further

What's the Most Tax-Friendly Way to Hold Bitcoin?
What's the Most Tax-Friendly Way to Hold Bitcoin?

Bitcoin (CRYPTO: BTC) has gained notoriety for a number of reasons, most obviously because it's up 97% year-to-date and has vastly outgained the S&P 500 over the past several years. With great gains

Here's Why Investors Shouldn't Panic on a Bad Market Day
Here's Why Investors Shouldn't Panic on a Bad Market Day

The market has had its fair share of ups and downs lately, but that doesn't mean investors should cash out or stop buying more great stocks. In this segment of Backstage Pass, recorded on Oct. 6

This Stock Has a 6% Dividend Yield and a $100 Billion Market Opportunity
This Stock Has a 6% Dividend Yield and a $100 Billion Market Opportunity

The past year and a half or so hasn't exactly been a great environment to own experience-based real estate -- and EPR Properties (NYSE: EPR) hasn't exactly seen its business thrive. However, in this

71% of Medicare Enrollees Make This Huge Mistake
71% of Medicare Enrollees Make This Huge Mistake

Millions of seniors rely on Medicare for health coverage, but that coverage isn't the same for everyone. That's because enrollees get choices when it comes to Medicare Part D drug plans. They can

Better Buy: Olo vs. Toast
Better Buy: Olo vs. Toast

A very big restaurant industry is getting even bigger. Consumer spending on restaurants is expected to increase from $863 billion in 2019 to $1.1 trillion by 2024, according to The Freedonia Group.

2 Cheap Growth Stocks That Could Be Even Better Buys in November
2 Cheap Growth Stocks That Could Be Even Better Buys in November

Over the past few weeks, many stocks have been falling in price. And while the temptation might be to scoop up shares right now, in some cases, you could be better off waiting. There are a couple of

5 Big-Name Stocks Expected to Increase Sales 356% to 1,605% by 2025
5 Big-Name Stocks Expected to Increase Sales 356% to 1,605% by 2025

Since the Great Recession ended more than 12 years ago, growth stocks have ruled the roost on Wall Street. A combination of historically low lending rates and ongoing quantitative easing measures

Could Johnson & Johnson's Booster Opportunity Be Better Than Pfizer's and Moderna's?
Could Johnson & Johnson's Booster Opportunity Be Better Than Pfizer's and Moderna's?

Pfizer (NYSE: PFE) has already won authorization to inoculate people with boosters of its COVID-19 vaccine, albeit thus far, only those in certain higher-risk groups. Moderna (NASDAQ: MRNA) and

Why Ocugen Stock Is Skyrocketing This Week
Why Ocugen Stock Is Skyrocketing This Week

Shares of Ocugen (NASDAQ: OCGN) were skyrocketing 41.4% this week as of the market close on Thursday, according to data from S&P Global Market Intelligence. There were several factors behind this

Cathie Wood Just Bought Shares of This Vaccine Underdog. Should You?
Cathie Wood Just Bought Shares of This Vaccine Underdog. Should You?

When you think of coronavirus vaccines using messenger RNA (mRNA), you probably think Pfizer and Moderna. The two companies burst into the forefront with mRNA technology last year, and since then

Why Netflix Investors Are So Excited About "Squid Game"
Why Netflix Investors Are So Excited About "Squid Game"

More than 111 million households around the world have already watched Squid Game, the dystopian South Korean drama released last month on Netflix (NASDAQ: NFLX). That makes it by far the most

PayPal Earnings: What Investors Need to Know
PayPal Earnings: What Investors Need to Know

PayPal (NASDAQ: PYPL) is firing on all cylinders. Since the beginning of 2020, the company has launched an array of new products, including a "buy now, pay later" service, support for

Starting Social Security at 62 Could Net You an Extra $20,000 in This Situation
Starting Social Security at 62 Could Net You an Extra $20,000 in This Situation

There are few hard-and-fast rules when it comes to Social Security. You may have heard some people say that it's not a good idea to sign up for benefits right away at 62 because you'll shrink your